"We were pleased that PEMGARDA once again grew year-over-year, now at 22% over 1Q in 2025" and "we are preparing for and looking forward to transitioning forward into an entirely new kind of COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results